[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[e-drug] Resuing bottles in drug manufacturing (3)
- From: Michael Anisfeld <manisfeld@globepharm.org>
- Date: Mon, 14 Jan 2002 09:30:55 -0500 (EST)
E-drug: Reusing bottles in drug manufacturing (3)
------------------------------------------------------------
Several years ago, as a Quality Assurance manager is a medium
size pharmaceutical manufacturing company, we evaluated the cost
of receiving back glass bottles and recycling them.
Our analyses showed the following problems
a. our operations were geared to processing (washing/drying)
thousands of bottles at a time - when bottles would be
returned, they would come back in ones-twos-etc., but not in
unique easy to take apart pallet loads.
b. we would have to sort the bottles by size
c. we would need space to store the bottles, and people to do
hand movement of the bottles, rather than fork lift truck
movement of thousands of bottles on one pallet
d. we would have to validate a washing cycle that could cope
with the vagaries of what people might do with the bottles
after their pharmaceutical use - we found bottles returned
with reside of acids, caustic, paint and other stuff that we
never identified! The range was so great as to render
effective cleaning validation impossible
e. and lastly, the analysis was performed in the late 1980s, and
we were about to move from glass to single-use plastic, as
significant cost saving measure - and the plastic bottles could
not withstand an effective hot water wash without deformation
The project economics loudly screamed that, while environmentally
friendly, our costs would rise significantly, to the point that we might
need to raise our prices by 15-20% to cover the recycling. The
project also screamed from a quality perspective that we would
never be able to guarantee that the recycled bottles were clean.
So the project never got off the ground.
Thought you might like the input. Intuitively recycling is the way to
go; practically in a pharmaceutical industry setting there are too
many problems, as stated above.
Michael Anisfeld
manisfeld@globepharm.org
www.globepharm.org
Globepharm
P.O. Box 589=20
Deerfield IL 60015
Ph: USA +1+847 914 0922
Fx: USA +1+847 914 0988
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html
|